ibrutinib
abbvie,janssen
[' ibru', 'cll']
a fantastic interview with paolo ghia ( ) on the outcomes of patients with cll 65 years treated with first-line ibrutinib, differences in clinical course and management of sars-cov2 infection in cll between the sequential pandemic phase &amp; more! #ash22 
The Video Journal of Hematological Oncology is dedicated to providing up-to-date information & international expertise on #HemOnc #LeuSM
#LymSM #MMsm #MPN #MDS